Skip to main content
Veterinary Medicines

Lewamizol 10% 100 mg/g Proszek do sporządzania roztworu doustnego

Authorised
  • Levamisole hydrochloride

Product identification

Medicine name:
Lewamizol 10% 100 mg/g Proszek do sporządzania roztworu doustnego
Active substance:
  • Levamisole hydrochloride
Target species:
  • Cattle
  • Pig
  • Chicken (hen)
  • Sheep
  • Goose
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Levamisole hydrochloride
    100.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • In drinking water use
    • Cattle
      • Meat and offal
        14
        day
    • Pig
      • Meat and offal
        28
        day
    • Chicken (hen)
      • Meat and offal
        7
        day
    • Sheep
      • Meat and offal
        21
        day
    • Goose
      • Meat and offal
        7
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AE01
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Biowet Drwalew Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Drwalewskie Zaklady Przemyslu Bioweterynaryjnego S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0762
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 11/07/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 11/07/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 11/07/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."